Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Mar 26, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment," is studying how a baby's cry can provide important information about their health and development, especially for newborns and premature infants. Researchers believe that the way a baby cries can reflect their brain function and overall well-being. By analyzing the sounds of crying, they hope to learn more about the baby's neurological development and identify any potential issues early on.

To participate in this study, babies must be either full-term (born after 37 weeks) or premature (born before 37 weeks) and must be born at the Saint-Etienne University Hospital. Parents or guardians need to give their consent for their child's participation and should be affiliated with a social security system. The trial is currently recruiting participants, and families can expect to provide samples of their baby's cries, which researchers will analyze. It’s important to note that babies with certain health issues or those whose parents cannot provide consent will not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • For a full-term baby \> 37 weeks
• • For a premature baby \< 37 weeks
• • Born in the maternity ward of the Saint-Etienne University Hospital
• • Holder of parental authority having received informed information about the study and their right to object
• • Holder of parental authority affiliated to or beneficiary of a social security system
• • Eutrophic between the 10th and 90th percentile on the neonatal curves)
• Exclusion Criteria:
• • Refusal of participation by the holder of parental authority
• • Antenatal pathology, nor perinatal asphyxia
• • Holder of minor parental authority
• • Holder of parental authority under curatorship or guardianship
• • Abnormal T1 audiological screening test.